No Data
CLSA PREMIUM: 2024 ANNUAL REPORT
CLSA PREMIUM (06877.HK): A total of 0.406 billion offer shares have been effectively accepted. The offer deadline has passed.
On April 1st, Gelonghui丨CLSA PREMIUM (06877.HK) announced that the offer will expire at 4:00 PM on April 1st, 2025, and that the offeror will not amend or extend the offer. At 4:00 PM on April 1st, 2025, the offeror has received five valid acceptances for a total of 406,245,000 offer shares, representing approximately 19.98% of the total issued share capital of the company as of the date of this joint announcement. Following the expiration of the offer, and accounting for the effective acceptances of the shares, the offeror and its concert parties will hold interests in 1,606,555,001 shares of the company.
CLSA Premium Limited Reports 2024 Financial Results and Strategic Changes
CLSA PREMIUM (06877) plans to rename itself as "Top Eminent Healthcare Group Limited".
CLSA PREMIUM (06877) announced that the Board of Directors recommends that Shareholders approve the company's name...
CLSA PREMIUM (06877) announced its performance for 2024 with a net profit of 11.338 million Hong Kong dollars, an increase of 15.2% year-on-year.
CLSA PREMIUM (06877) announced the 2024 performance, with total revenue of approximately 0.103 billion Hong Kong dollars...
Express News | CLSA Premium FY Net Income HKD 11.3 Million